Respiratory syncitial virus

This month’s MabDesign market analysis gives you an overview of market dynamics and projects in development targeting respiratory syncitial virus (RSV).

Infectious diseases

maladies infectieuses, pipeline, marché,

This month, MabDesign’s market analysis gives you an overview of projects in development in the field of infectious diseases.

breast cancer

marché cancer du sein, cancer du sein, analyse marché

The MabDesign market analysis for this month of pink October gives you an overview of market dynamics and projects in development targeting the treatment of breast cancer.

Multiple Sclerosis

Marché sclérose en plaques

This month’s MabDesign market analysis gives you an overview of market dynamics and development projects targeting the treatment of multiple sclerosis.

Glioblastoma

marché glioblastome

This month’s MabDesign market analysis gives you an overview of market dynamics and pipeline projects targeting the glioblastoma.

Exosomes and extracellular vesicles

exosomes ; vésicules extracellulaires

Long considered as cellular debris with no biological function, exosomes, and more generally extracellular vesicles (EVs), are now recognized as vectors of biological material with a role in intercellular communication. The building of knowledge on the subject has not only highlighted their role in certain pathologies, but also revealed their potential as biomarkers and therapeutic tools.

Advanced therapy medicinal products: from the lab to the patient’s bed

téhrapie génique et cellulaire ; CAR-T ; MTIs ; médicaments thérapie innovante

Advanced therapy medicinal products (ATMPs) explore new therapeutic approaches based on genome modification, manipulation of patient or healthy donor cells and other innovative methods, representing a major transition from traditional medicine to more personalized and targeted medicine.

Prophylactic or Therapeutic : what does the future hold for vaccines ?

vaccins innovation

Fuelled by decades of innovation, vaccines are an essential tool in the fight against disease. Historically focused on prophylaxis to prevent the spread of infectious diseases, new generations of vaccines are now being developed and/or are already available in other therapeutic areas including oncology. Historically focused on prophylaxis and infectious diseases, they are now opening up to new avenues of development, with a range of vaccine technologies, the positioning of vaccines as a new therapeutic tool, and the opening up of other therapeutic areas such as oncology.